Skip to main content
Clinical Trials/CTRI/2024/05/067255
CTRI/2024/05/067255
Not yet recruiting
Not Applicable

DEVELOPMENT OF A COMPREHENSIVE PERINATAL AND NEONATAL PREDICTIION MODEL FOR EARLY ONSET SEPSIS IN PRETERM NEONATES BORN LESS THAN OR EQUAL TO 34 WEEKS OF GESTATION – A PROSPECTIVE COHORT STUDY

Lady Hardinge Medical College NewDelhi1 site in 1 country1,180 target enrollmentStarted: May 27, 2024Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Lady Hardinge Medical College NewDelhi
Enrollment
1,180
Locations
1
Primary Endpoint
Development of a “comprehensive perinatal and neonatal prediction model“

Overview

Brief Summary

•       Most of the currently available early onset sepsis risk calculators are based on perinatal risk factors and are derived from the data collected in developed countries, which has altogether different organism profile (gram positive>> gram negative in former), clinical course, and outcome than developing countries  and risk factor based approach  leads to unnecessary exposure of antibiotics during the 1st week of life among asymptomatic neonates. Hence this  prospective cohort study is  aimed to develop comprehensive perinatal risk factor and neonatal clinical parameter based prediction model for early onset neonatal sepsis for babies born ≤ 34 weeks of gestation in developing country like India.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
0.00 Day(s) to 3.00 Day(s) (—)
Sex
All

Inclusion Criteria

  • All neonates born with ≤34 weeks of gestation.

Exclusion Criteria

  • Major congenital anomaly (antenatally diagnosed or visible at birth).

Outcomes

Primary Outcomes

Development of a “comprehensive perinatal and neonatal prediction model“

Time Frame: Till discharge or death which ever is earlier

Secondary Outcomes

  • 1.Performance of model for culture positive sepsis(2.Performance of model for probable sepsis)

Investigators

Sponsor
Lady Hardinge Medical College NewDelhi
Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

DR SUSHMA NANGIA

Lady hardinge medical college

Study Sites (1)

Loading locations...

Similar Trials